AAA
Affinity Asset Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.38M | Hold |
152,252
| – | – | 0.6% | 40 |
|
|
2025
Q1 | $5.11M | Sell |
152,252
-307,748
| -67% | -$10.3M | 0.49% | 34 |
|
|
2024
Q4 | $23.5M | Buy |
460,000
+60,000
| +15% | +$3.07M | 3.15% | 8 |
|
|
2024
Q3 | $20.4M | Sell |
400,000
-115,000
| -22% | -$5.88M | 2.79% | 8 |
|
|
2024
Q2 | $23.1M | Buy |
515,000
+45,000
| +10% | +$2.02M | 2.66% | 6 |
|
|
2024
Q1 | $22M | Buy |
470,000
+22,905
| +5% | +$1.07M | 2.72% | 4 |
|
|
2023
Q4 | $15.9M | Sell |
447,095
-2,905
| -0.6% | -$103K | 2.91% | 10 |
|
|
2023
Q3 | $13.4M | Buy |
+450,000
| New | +$13.4M | 3.76% | 7 |
|